Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase

Elena V. Gazina, Eric D. Smidansky, Jessica K. Holien, David N. Harrison, Brett A. Cromer, Jamie J. Arnold, Michael W. Parker, Craig E. Cameron, Steven Petrou

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Amiloride and its derivative 5-(N-ethyl-N-isopropyl)amiloride (EIPA) were previously shown to inhibit coxsackievirus B3 (CVB3) RNA replication in cell culture, with two amino acid substitutions in the viral RNA-dependent RNA polymerase 3D pol conferring partial resistance of CVB3 to these compounds (D. N. Harrison, E. V. Gazina, D. F. Purcell, D. A. Anderson, and S. Petrou, J. Virol. 82:1465-1473, 2008). Here we demonstrate that amiloride and EIPA inhibit the enzymatic activity of CVB3 3D pol in vitro, affecting both VPg uridylylation and RNA elongation. Examination of the mechanism of inhibition of 3D pol by amiloride showed that the compound acts as a competitive inhibitor, competing with incoming nucleoside triphosphates (NTPs) and Mg 2+. Docking analysis suggested a binding site for amiloride and EIPA in 3D pol, located in close proximity to one of the Mg 2+ ions and overlapping the nucleotide binding site, thus explaining the observed competition. This is the first report of a molecular mechanism of action of nonnucleoside inhibitors against a picornaviral RNA-dependent RNA polymerase.

Original languageEnglish (US)
Pages (from-to)10364-10374
Number of pages11
JournalJournal of virology
Issue number19
StatePublished - Oct 2011

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Immunology
  • Insect Science
  • Virology


Dive into the research topics of 'Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase'. Together they form a unique fingerprint.

Cite this